1. Home
  2. VRAX vs YHC Comparison

VRAX vs YHC Comparison

Compare VRAX & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.35

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.28

Market Cap

2.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
YHC
Founded
2013
2021
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.2M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
VRAX
YHC
Price
$2.35
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.3K
★ 53.8K
Earning Date
11-20-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 8.28
Revenue
N/A
★ $1,120,622.00
Revenue This Year
N/A
$1,254.00
Revenue Next Year
N/A
$21.74
P/E Ratio
★ N/A
$0.16
Revenue Growth
N/A
★ 86.42
52 Week Low
$0.10
$0.02
52 Week High
$13.19
$2.72

Technical Indicators

Market Signals
Indicator
VRAX
YHC
Relative Strength Index (RSI) 35.91 42.04
Support Level $2.15 $1.24
Resistance Level $3.01 $1.60
Average True Range (ATR) 0.18 0.12
MACD -0.03 -0.00
Stochastic Oscillator 19.05 17.95

Price Performance

Historical Comparison
VRAX
YHC

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

Share on Social Networks: